Insights on the Gastrointestinal Endoscopy Global Market to 2031 - Featuring Boston Scientific, Medtronic, Ambu and Teleflex Among Others

2022-10-15 08:00:35 By : Mr. Michael Ma

Dublin, Oct. 10, 2022 (GLOBE NEWSWIRE) -- The "Gastrointestinal Endoscopy Market - A Global and Regional Analysis: Focus on Type, End User, and Region - Analysis and Forecast, 2022-2031" report has been added to ResearchAndMarkets.com's offering.

The global gastrointestinal endoscopy market was valued at $13.40 billion in 2021 and is anticipated to reach $25.75 billion by 2031, witnessing a CAGR of 6.24% during the forecast period 2022-2031.

The market is driven by factors such as the increasing prevalence of gastrointestinal diseases, rising preference for minimally invasive surgeries, growing demand for capsule endoscopy, the shift from reusable endoscopes to disposable endoscopes, and technological advancements in the field of robot-assisted endoscopes and AI-based devices.

The gastrointestinal endoscopy market is in the developed phase. The increasing demand for single-use endoscopes such as duodenoscopes, gastroscopes, and colonoscopes, increasing demand for capsule endoscopy, and the integration of industry with robotics and AI are some of the major opportunities in the global gastrointestinal endoscopy market.

Furthermore, some of the current key trends in the market are the shift from conventional surgeries to robot-assisted surgery, the development of single-use endoscopes, the rising demand for minimally invasive procedures, and the increasing number of product launches among market players.

The COVID-19 pandemic has impacted practically all sectors and social functions worldwide, including the gastrointestinal endoscopy market. COVID-19 led to a decline in the global gastrointestinal endoscopy market, as elective and surgical procedures were stopped during the lockdown.

Overall, the supply side was negatively impacted, especially during the peak of the COVID-19 pandemic. The significantly high number of endoscopy procedures resumed after the restrictions were lifted, which offset the negative impact and led to the growth of the market in 2021.

In addition to this, the COVID-19 pandemic also helped in the adoption of single-use endoscopes. Single-use endoscopes eliminate the risk of cross-contamination, which turned out to be a favorable condition for their adoption during the COVID-19 pandemic.

Recent Developments in the Global Gastrointestinal Endoscopy Market

In May 2022, Limaca-Medical received breakthrough device recognition by FDA for its Precision-GI endoscopic ultrasound biopsy device.

In February 2022, Ambu A/S received FDA approval for its Ambu aScope Gastro and Ambu aBox 2.

In November 2021, Medtronic plc received 510 (k) clearance from FDA for its Pillcam Small Bowel 3 system for remote endoscopy procedures.

In August 2021, Ambu received CE mark approval for its Ambu aScope Duodeno, a disposable duodenoscope.

Demand - Drivers and Limitations

Following are the drivers for the global gastrointestinal endoscopy market:

Increasing Prevalence of Chronic Gastrointestinal Diseases

Upsurge in Adoption of Disposable Gastrointestinal Endoscopes

Rising Inclination toward Minimally Invasive Procedures

Shift toward Wireless Capsule Endoscopy

The market is expected to face some limitations as well due to the following challenges:

Dearth of Skilled Healthcare Professionals

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the prominent established names in this market are:

KARL STORZ SE & Co. KG

HuiZhou Xzing Technology Co., Ltd.

1 Markets 1.1 Global Market Outlook 1.2 Industry Outlook 1.3 Impact of COVID-19 on Global Gastrointestinal Endoscopy Market 1.4 Business Dynamics 1.4.1 Impact Analysis 1.4.2 Business Drivers 1.4.2.1 Increasing Prevalence of Chronic Gastrointestinal Diseases 1.4.2.2 Upsurge in Adoption of Disposable Gastrointestinal Endoscopes 1.4.2.3 Rising Inclination toward Minimally Invasive Procedures 1.4.2.4 Shift toward Wireless Capsule Endoscopy 1.4.3 Business Challenges 1.4.3.1 Dearth of Skilled Healthcare Professionals 1.4.3.2 Lack of Reimbursement Frameworks 1.4.4 Business Opportunities 1.4.4.1 Leveraging Synergies to Diversify Business Portfolio 1.4.4.2 Technological Advancements in Gastrointestinal Endoscopy Devices

2 Global Gastrointestinal Endoscopy Market (by Type) 2.1 Overview 2.2 Opportunity Assessment 2.3 Gastrointestinal Endotherapy 2.3.1 ERCP Devices 2.3.2 Gastrointestinal Stents 2.3.2.1 Esophageal Stents 2.3.2.2 Biliary Stents 2.3.2.3 Pancreatic Stents 2.3.3 Balloon Dilators 2.3.4 Ultrasound Endoscopes 2.3.5 Biopsy Devices 2.3.5.1 Biopsy Forceps 2.3.5.2 Polypectomy Snares 2.3.5.3 Other Biopsy Devices 2.3.6 Hemostasis Devices 2.3.7 Retrieval Devices 2.3.8 Others 2.4 Gastrointestinal Endoscopes and Endoscopic Systems 2.4.1 Gastrointestinal Videoscopes 2.4.1.1 Gastroscopes 2.4.1.2 Colonoscopes 2.4.1.3 Duodenoscopes 2.4.1.4 Sigmoidoscopes 2.4.1.5 Enteroscopes 2.4.1.6 Anoscopes 2.4.2 Visualization Systems 2.4.3 Capsule Endoscopes

3 Global Gastrointestinal Endoscopy Market (by End User) 3.1 Overview 3.2 Opportunity Assessment 3.3 Hospitals 3.4 Ambulatory Surgery Centers 3.5 Others

5 Markets - Competitive Benchmarking and Company Profiles 5.1 Competitive Benchmarking 5.1.1 Competitive Landscape 5.1.1.1 Key Strategies and Developments 5.1.1.2 Regulatory and Legal Activities 5.1.1.3 Funding Activities 5.1.1.4 New Offerings 5.1.1.5 Mergers and Acquisitions 5.1.1.6 Partnerships, Collaborations, and Business Expansions 5.2 Market Share Analysis 5.3 Company Profiles 5.3.1 Established Companies 5.3.1.1 Boston Scientific Corporation 5.3.1.1.1 Company Overview 5.3.1.1.2 Role of Boston Scientific Corporation in the Gastrointestinal Endoscopy Market 5.3.1.1.3 Financials 5.3.1.1.4 Recent Developments 5.3.1.1.5 Regional Penetration 5.3.1.1.6 Analyst Perspectives 5.3.1.2 Medtronic plc 5.3.1.2.1 Company Overview 5.3.1.2.2 Role of Medtronic plc in the Gastrointestinal Endoscopy Market 5.3.1.2.3 Financials 5.3.1.2.4 Recent Developments 5.3.1.2.5 Regional Penetration 5.3.1.2.6 Analyst Perspectives 5.3.1.3 KARL STORZ SE & Co. KG 5.3.1.3.1 Company Overview 5.3.1.3.2 Role of KARL STORZ SE & Co. KG in the Global Gastrointestinal Endoscopy Market 5.3.1.3.3 Recent Developments 5.3.1.3.4 Regional Penetration 5.3.1.3.5 Analyst Perspectives 5.3.1.4 Ambu A/S 5.3.1.4.1 Company Overview 5.3.1.4.2 Role of Ambu A/S in the Global Gastrointestinal Endoscopy Market 5.3.1.4.3 Financials 5.3.1.4.4 Recent Developments 5.3.1.4.5 Regional Penetration 5.3.1.4.6 Analyst Perspectives 5.3.1.5 Teleflex Incorporated 5.3.1.5.1 Company Overview 5.3.1.5.2 Role of Teleflex Incorporated in the Gastrointestinal Endoscopy Market 5.3.1.5.3 Financials 5.3.1.5.4 Regional Penetration 5.3.1.5.5 Analyst Perspectives 5.3.1.6 HOYA Corporation 5.3.1.6.1 Company Overview 5.3.1.6.2 Role of HOYA Corporation in the Global Gastrointestinal Endoscopy Market 5.3.1.6.3 Financials 5.3.1.6.4 Recent Developments 5.3.1.6.5 Regional Penetration 5.3.1.6.6 Analyst Perspectives 5.3.1.7 Olympus Corporation 5.3.1.7.1 Company Overview 5.3.1.7.2 Role of Olympus Corporation in the Global Gastrointestinal Endoscopy Market 5.3.1.7.3 Financials 5.3.1.7.4 Recent Developments 5.3.1.7.5 Regional Penetration 5.3.1.7.6 Analyst Perspectives 5.3.1.8 FUJIFILM Holdings Corporation 5.3.1.8.1 Company Overview 5.3.1.8.2 Role of FUJIFILM Holdings Corporation in the Global Gastrointestinal Endoscopy Market 5.3.1.8.3 Financials 5.3.1.8.4 Recent Developments 5.3.1.8.5 Regional Penetration 5.3.1.8.6 Analyst Perspectives 5.3.1.9 Cook Group Inc 5.3.1.9.1 Company Overview 5.3.1.9.2 Role of Cook Group Inc in the Global Gastrointestinal Endoscopy Market 5.3.1.9.3 Recent Developments 5.3.1.9.4 Regional Penetration 5.3.1.9.5 Analyst Perspectives 5.3.1.10 SonoScape Medical Corp. 5.3.1.10.1 Company Overview 5.3.1.10.2 Role of SonoScape Medical Corp in the Global Gastrointestinal Endoscopy Market 5.3.1.10.3 Recent Developments 5.3.1.10.4 Regional Penetration 5.3.1.10.5 Analyst Perspectives 5.3.2 Start-ups 5.3.2.1 EndoMed Systems GmbH 5.3.2.1.1 Company Overview 5.3.2.1.2 Role of EndoMed Systems GmbH in the Global Gastrointestinal Endoscopy Market 5.3.2.1.3 Regional Penetration 5.3.2.1.4 Analyst Perspectives 5.3.2.2 CapsoVision, Inc. 5.3.2.2.1 Company Overview 5.3.2.2.2 Role of CapsoVision, Inc. in the Gastrointestinal Endoscopy market 5.3.2.2.3 Recent Developments 5.3.2.2.4 Regional Penetration 5.3.2.2.5 Analyst Perspectives 5.3.2.3 HuiZhou Xzing Technology Co., Ltd. 5.3.2.3.1 Company Overview 5.3.2.3.2 Role of HuiZhou Xzing Technology Co., Ltd. in the Global Gastrointestinal Endoscopy Market 5.3.2.3.3 Recent Developments 5.3.2.3.4 Regional Penetration 5.3.2.3.5 Analyst Perspectives 5.3.2.4 Endogene Ltd. 5.3.2.4.1 Company Overview 5.3.2.4.2 Role of Endogene Ltd. in the Gastrointestinal Endoscopy market 5.3.2.4.3 Regional Penetration 5.3.2.4.4 Analyst Perspectives 5.3.2.5 Envaste Limited 5.3.2.5.1 Company Overview 5.3.2.5.2 Role of Envaste Limited in the Global Gastrointestinal Endoscopy Market 5.3.2.5.3 Regional Penetration 5.3.2.5.4 Analyst Perspectives

For more information about this report visit https://www.researchandmarkets.com/r/4cbwj6

MarketWatch Picks has highlighted these products and services because we think readers will find them useful; the MarketWatch News staff is not involved in creating this content. And at a 2009 shareholder meeting, Buffett noted that the first best thing you can do to protect against inflation is to invest in yourself and your skills: “If you’re the best teacher, if you’re the best surgeon, if you’re the best lawyer, you will get your share of the national economic pie regardless of the value of whatever the currency may be,” he said.

Inflation and higher interest rates could be here to stay. BofA says changing demographics, deglobalization, and underinvestment in energy production have created a new “regime” for the global economy.

NIO Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $NIO performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.

The U.S. stock market took an unusual swing after Thursday’s inflation report. “Shortly after the open, the S&P 500 index had dropped nearly 4% from its pre-market highs before staging an epic rally of over 5%,” Bespoke Investment Group said in a note Friday. “Even in this ‘all or nothing’ type of market environment, reversals of that magnitude are rare.”

Investors were surprised by the big rally in the stock market on Thursday, but Friday brought another dose of reality and disappointment. After having posted monumental gains despite high readings on inflation, the Nasdaq Composite (NASDAQINDEX: ^IXIC) closed at its worst level of the year, and the S&P 500 (SNPINDEX: ^GSPC) and Dow Jones Industrial Average (DJINDICES: ^DJI) gave up most of their advances from earlier in the week. One of the biggest stock stories of the past several years has been Tesla (NASDAQ: TSLA).

Investors seemingly can’t stop trying to pick a stock market bottom, no matter how bad the news—and it continues to backfire. Consider: This past Thursday, September’s consumer inflation report came in much hotter than expected, with the core CPI hitting a 40-year high. The initial response was exactly what you’d expect—the traded down as much as 2.4%—but then it started rallying…and rallying.

Everyone is hoping the market might be bottoming and by the recent actions of Bank of America clients, some evidently think the lows must be in sight. Last week, BofA customers splashed out $6.1 billion on US stocks, in what amounted to the third largest inflow since 2008. While the bank has stated it is not as confident the bottom is quite so close, it’s not hard to see why investors feel the time is right to lean into equities. The widespread losses have left scores of beaten-down stocks looki

The U.S. Treasury Department put an item on its agenda Friday to start talking with primary dealers about the potential for it to buy back some of its older debt to help keep markets functioning smoothly.

These diversified natural-resource giants have solid balance sheets, earnings, and dividends. All that they need is a rebound in commodity prices.

A look at the shareholders of Advanced Micro Devices, Inc. ( NASDAQ:AMD ) can tell us which group is most powerful. The...

Nikola (NKLA) founder Trevor Milton was found guilty of three counts of criminal fraud on Friday in a case accusing him of spreading lies about the electric truck startup for his own personal benefit.

Making investments pay out for the long term is the true challenge in today’s market environment. The series of headwinds piling up – from persistently high inflation to rising interest rates to slowing demand to bureaucratic bloat – are rising to hurricane force, and renewing investors’ attention to defensive stocks. It’s only logical. The classic defensive stock, the dividend payer, ensures an income stream no matter how the markets move, and if the yield is high enough, these stocks can also

Shares of electric vehicle (EV) manufacturer Rivian (NASDAQ: RIVN) sank in Friday morning trading. At that time, the tech-heavy Nasdaq Composite was down by 2.3%. A number of factors were working against Rivian's shares.

Goldman is staying long and strong Tesla. Here's why.

Jeff Bezos, the founder of Amazon, started his 2000 shareholder letter with the word "ouch." The company's stock had fallen more than 80% in the past year, a tough time for shareholders when the dot-com bubble had burst, and Wall Street was selling everything out of fear. Today, Amazon is one of the world's largest companies, which means that 2000 was a wonderful time to buy shares.

Shares of Tesla (NASDAQ: TSLA) were initially trading higher at the market open on Friday before market traders turned their attention back to the economy, which sent most stocks down today. As of 12:42 p.m. ET, the stock was trading down 5.4%, while the Nasdaq Composite was down 2.3%. The sell-off comes after another analyst issued a positive note on Tesla ahead of next week's third-quarter earnings report.

Dividends are the bread and butter of income investors. You don't need to sell your assets or spend hours every day managing your accounts. Instead, dividend stocks simply generate income on their own. Putting together a portfolio that generates at least … Continue reading → The post How to Make $1,000 a Month in Dividends appeared first on SmartAsset Blog.

In the midst of a bear market, with rising interest rates and the threat of a prolonged recession in the air, real estate investment trust (REIT) stocks have endured tremendous price declines. Given this, it isn’t easy to find REITs that could see dividend increases soon. Two questions come to mind. Why would a company raise its dividend when the yield is already increasing with each drop in price? And how do you find REITs with the dividend well-covered by funds from operations (FFO) and with s

This week’s worse-than-expected inflation report led to turmoil in more than one market, but you only read about one of them. What got far less attention was the flurry of excitement that the inflation report caused in the normally-staid I-bond market.

The Senior Citizen’s League says there ‘may be no COLA payable in 2024.'